Plex Pharmaceuticals

Yale’s Horwich receives the 2016 Albany Prize.

Plex Pharmaceuticals awarded $670,865 grant funding from The Michael J. Fox Foundation for Parkinson's Research.

Plex Pharmaceuticals Announces Continuation of Funding of NIH SBIR Phase I Grant and Key Appointments to Management and Scientific Advisory Board.

Plex Pharmaceuticals awarded Phase I SBIR grant to treat Dengue virus infection.

Interview With Sridhar Prasad, PhD., Founder Of Plex Pharmaceuticals http://goo.gl/j8gPjH

Allan E. Rubenstein, MD and Khatereh Ahmadi, PhD to assume roles in Plex Pharmaceuticals Inc.

Plex Pharmaceuticals and Professor R. Padmanabhan of Georgetown University announce a collaboration to develop inhibitors of Dengue and West Nile virus proteases.

Plex and LD Biopharma Have Agreed to Provide Integrated Discovery Services for structure-based and fragment-based drug discovery.

California: Safe harbour http://goo.gl/b4XBsd

Plex receives a $279,068 grant award to develop selective and dual-acting HSP90 and TRAP1 inhibitors

Novel, Selective and Potent Brain-penetrant Small Molecule Inhibitors of Cytosolic Hsp90 https://goo.gl/9RIwrB

How the Recession Fueled San Diego Biotech Innovation http://goo.gl/dgbhI6

Plex receives a $549,882 grant award to develop novel, selective and potent brain-penetrable small molecule cytosolic Hsp90 inhibitors